In the BioHarmony Drug Report Database

"Preview" Icon

Mefloquine

Lariam, Mefloquine (mefloquine) is a small molecule pharmaceutical. Mefloquine was first approved as Lariam on 1989-05-02. It is used to treat falciparum malaria, malaria, and vivax malaria in the USA. It is known to target adenosine receptor A1, adenosine receptor A2a, and purine nucleoside phosphorylase.

 

Trade Name

 

Lariam, Mefloquine
 

Common Name

 

mefloquine
 

ChEMBL ID

 

CHEMBL416956
 

Indication

 

falciparum malaria, malaria, vivax malaria
 

Drug Class

 

Image (chem structure or protein)

Mefloquine structure rendering